Relevant bibliographies by topics / Conduct disorders

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Conduct disorders'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 April 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Conduct disorders.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Conduct disorders"

1

Hill, Jonathan. "Conduct disorders." Psychiatry 4, no. 7 (July 2005): 57–60. http://dx.doi.org/10.1383/psyt.2005.4.7.57.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Buitelaar, Jan K., Kirsten C. Smeets, Pierre Herpers, Floor Scheepers, Jeffrey Glennon, and Nanda N. J. Rommelse. "Conduct disorders." European Child & Adolescent Psychiatry 22, S1 (December 6, 2012): 49–54. http://dx.doi.org/10.1007/s00787-012-0361-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

HARADA, YUZURU, YURI SATOH, AYAKO SAKUMA, JUNKO IMAI, TUNEMI TAMARU, TOHRU TAKAHASHI, and NAOJI AMANO. "Behavioral and developmental disorders among conduct disorder." Psychiatry and Clinical Neurosciences 56, no. 6 (December 2002): 621–25. http://dx.doi.org/10.1046/j.1440-1819.2002.01065.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Conner, Bradley T., and John E. Lochman. "Comorbid Conduct Disorder and Substance Use Disorders." Clinical Psychology: Science and Practice 17, no. 4 (December 2010): 337–49. http://dx.doi.org/10.1111/j.1468-2850.2010.01225.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Scott, Stephen. "Conduct disorders in children." BMJ 334, no. 7595 (March 29, 2007): 646. http://dx.doi.org/10.1136/bmj.39161.370498.be.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Forness, Steven R., Kenneth A. Kavale, and Michael Lopez. "Conduct Disorders in School." Journal of Emotional and Behavioral Disorders 1, no. 2 (April 1993): 101–8. http://dx.doi.org/10.1177/106342669300100203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Short, Roxanna M. L., Wendy J. Adams, Matthew Garner, Edmund J. S. Sonuga-Barke, and Graeme Fairchild. "Attentional Biases to Emotional Faces in Adolescents with Conduct Disorder, Anxiety Disorders, and Comorbid Conduct and Anxiety Disorders." Journal of Experimental Psychopathology 7, no. 3 (June 26, 2016): 466–83. http://dx.doi.org/10.5127/jep.053915.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kostic, Jelena, Milkica Nesic, Miodrag Stankovic, Olivera Zikic, and Jasminka Markovic. "Evaluating empathy in adolescents with conduct disorders." Vojnosanitetski pregled 73, no. 5 (2016): 429–34. http://dx.doi.org/10.2298/vsp150121031k.

Full text
Abstract:
Background/Aim. According to currently available data, there is no research dealing with evaluating empathy in adolescents with conduct disorders in our region. The aim of the research was to examine the differences in the severity of cognitive and affective empathy in adolescents with and with no conduct disorder, as well as to examine the relationship between cognitive and affective empathy and the level of externalization in adolescents with conduct disorder. Methods. This research was conducted on 171 adolescents, aged 15 to 18, using the Interpersonal Reactivity Index, Youth Self- Report and a Questionnaire constructed for the purpose of this research. Results. The results showed that adolescents with conduct disorder had significantly lower scores for Perspective Taking (t = 3.255, p = 0.001), Fantasy (t = 2.133, p = 0.034) and Empathic Concern (t = 2.479, p = 0.014) compared to the adolescents in the control group, while the values for Personal Distress (t = 1.818, p = 0.071) were higher compared to the control group, but the difference was not statistically significant. The study showed a statistically significant negative correlation between Perspective Taking and aggression (r = - 0.318, p = 0.003) and a negative correlation between Perspective Taking and the overall level of externalizing problems (r = -0.310, p = 0.004) in the group of adolescents with conduct disorder. Conclusion. This research contributes to better understanding of behavioral disorders in terms of individual factors, especially empathic reactivity. Preventive work with young people who have behavioral problems associated with empathy deficit disorder proved to be an important tool in preventing the development, or at least relieving the symptoms, of this ever more common disorder.
APA, Harvard, Vancouver, ISO, and other styles
9

Kutcher, S. P., P. Marton, and M. Korenblum. "Relationship between Psychiatric Illness and Conduct Disorder in Adolescents." Canadian Journal of Psychiatry 34, no. 6 (August 1989): 526–29. http://dx.doi.org/10.1177/070674378903400608.

Full text
Abstract:
Ninety-six psychiatrically ill adolescents admitted to an adolescent inpatient service were systematically assessed to determine the morbidity of conduct disorder (CD), with other Axis I psychiatric disorders. Twenty-six (27%) met DSM-111 criteria for CD in addition to other Axis I disorders. A CD diagnosis was significantly associated with substance abuse, and attention deficit disorder with hyperactivity. Although CD was found in 21 % of depressives it was more commonly found inpatients with psychotic disorders (25 %) and bipolar (42 %) disorders. These findings suggest that CD may be commonly found in a variety of adolescent psychiatric disorders. The implications of this finding for pharmacologic treatment of CD, the clinical assessment of the CD patient, and possible relationships between CD and adolescent psychiatric disorders are discussed.
APA, Harvard, Vancouver, ISO, and other styles
10

Gottlieb, Susan E., and Stanford B. Friedman. "Conduct Disorders in Children and Adolescents." Pediatrics In Review 12, no. 7 (January 1, 1991): 218–23. http://dx.doi.org/10.1542/pir.12.7.218.

Full text
Abstract:
Conduct disorder is the most prevalent psychopathologic condition of childhood. It is characterized by a persistent and repetitive pattern of aggressive, noncompliant, intrusive, and poorly self-controlled behaviors that violate either the rights of others or age-appropriate societal norms.1 These behaviors have a significant impact on the daily functioning of the child or adolescent and on the ability of parents and other adults to manage them. The specific behavioral criteria for the diagnosis of conduct disorder can be conceptualized as either aggressive or nonaggressive in type (Table 1). Examples of aggressive behaviors are physical fighting and bullying, assault, vandalism, purse snatching, physical cruelty to persons or animals, breaking and entering, and arson. More serious aggressive behaviors are armed robbery, rape, and extortion. Nonaggressive behaviors of conduct disorder include substance abuse, persistent truancy, running away from home overnight, frequent lying in a variety of social settings, theft not involving a confrontation with a victim, and chronic violation of rules or the basic rights of others. Three subtypes of conduct disorder are identified in the Diagnostic and Statistical Manual of Mental Disorders, revised 3rd edition.1 These are descriptions of the functional contexts in which the particular behavior problems occur. The group type involves problematic behaviors that occur as part of an activity with peers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Conduct disorders"

1

Kalantari-Darani, Mehrdad. "Conduct disorders in preschool children." Thesis, King's College London (University of London), 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241820.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Green, Tara. "Risks associated with conduct disorder in girls." Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=81251.

Full text
Abstract:
Conduct disorder is the second most common psychiatric disorder in adolescent girls. In a secondary analysis of an existing data set from a study of pregnant adolescent girls, recruited from three different sites in a Canadian city (N = 252), possible predictors of conduct disorder were examined. The National Institute of Mental Health (NIMH) Diagnostic Interview Schedule (DIS) was used to measure conduct disorder. To investigate possible risk factors, three instruments were used: (1) Childhood Trauma Questionnaire (CTQ), (2) Parental Bonding Instrument, and (3) Knowledge of Infant Development Inventory (KIDI). In a stepwise regression analysis, conduct disorder was found to be significantly associated with four risk factors: high levels of overall abuse as children, placement in foster care, few years of schooling and lack of paternal care. A possible preventive program, to encourage girls with conduct disorder to stay in school and cope with past histories of abuse, is discussed.
APA, Harvard, Vancouver, ISO, and other styles
3

Harris, Gene A. "Ecological risk factors and severity of child conduct problems /." Thesis, Connect to this title online; UW restricted, 2001. http://hdl.handle.net/1773/8987.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wainwright, Anita. "Parental Substance Abuse Attributes to Conduct Disorders and Juvenile Delinquency." Youngstown State University / OhioLINK, 2000. http://rave.ohiolink.edu/etdc/view?acc_num=ysu1007582388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hawes, David Psychology Faculty of Science UNSW. "The treatment of conduct problems in children with callous-unemotional traits." Awarded by:University of New South Wales. School of Psychology, 2004. http://handle.unsw.edu.au/1959.4/20660.

Full text
Abstract:
The aim of this study was to determine the impact of callous-unemotional (CU) traits on treatment outcomes and processes in a 10-week behavioural parent training intervention with young boys referred for conduct problems (n=55, mean age 6.29 years). The study represents the first investigation of this risk factor in an early intervention trial, and extends the body of research examining the predictive utility of childhood CU traits in relation to subsequent antisocial behaviour. As predicted, CU traits were associated with greater conduct problems at pre-treatment, and these traits were related to poor treatment outcomes at 6-month follow-up even when controlling for baseline conduct problem severity. Consistent with the low levels of fearful inhibitions characteristic of the CU temperament, the behaviour of boys with high CU traits was less responsive to time-out discipline than that of boys without CU traits. Boys with high levels of CU traits also reacted with less affect to this discipline. The effects of CU traits on treatment outcomes and processes were not related to differences in treatment implementation by parents. These findings provide evidence that conduct problems in boys with CU traits are less responsive to changes in parenting processes than those of boys without these traits, and present important implications for the role of child temperament in the treatment of conduct problems.
APA, Harvard, Vancouver, ISO, and other styles
6

Gemmell, William David. "The genesis of conduct disorders in early adolescence, a multi-factoral approach." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq24587.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, Kathleen Marg. "Differential diagnosis of oppositional defiant and conduct disorder utilizing the Millon Adolescent Clinical Inventory." Virtual Press, 2007. http://liblink.bsu.edu/uhtbin/catkey/1370878.

Full text
Abstract:
Studying disruptive behavior disorders in adolescents is critical; however, there is a paucity of literature on methods for differentially diagnosing the two main disruptive behavior disorders: Oppositional Defiant Disorder and Conduct Disorder. Conduct Disorder is defined as a persistent pattern of behavior where the basic rights of others or other major social norms are violated whereas Oppositional Defiant Disorder is usually diagnosed in childhood or adolescence, and is defined by a pattern of disobedient, hostile, or defiant behavior towards authority figures. Despite some similarities in presentation, the majority of research supports the notion that these two disorders are distinct. Finding accurate ways to differentiate these two disorders is important for discovering and implementing empirically validated treatments. The primary purpose of this study was to determine how the Millon Adolescent Clinical Inventory, a commonly used self-report scale, distinguished between adolescents presenting with either Oppositional Defiant or Conduct Disorder who had been admitted to a residential treatment facility. A secondary component of the current study examined gender differences in the two disorders.Multivariate Analysis of Variance was used to determine if the two diagnostic or gender groups were significantly different. If so, discriminant function analysis was employed to determine where the difference occurred. Although some scales approached significance, there were no statistical differences among adolescents with Conduct Disorder and Oppositional Defiant Disorder across any of the dependent variables. There were, however, gender and age differences found across several scales. Unfortunately, because there were no interactions with diagnosis on any scales, differences occurred equally among adolescents from either diagnostic group. This result raises questions as to whether the Millon Adolescent Clinical Inventory is a useful diagnostic instrument for disruptive behavior disorders. This instrument may be more useful to determine individual characteristics that would impact treatment than as an instrument for researchers studying empirically validated interventions for Conduct Disorder and Oppositional Defiant Disorder.
Department of Educational Psychology
APA, Harvard, Vancouver, ISO, and other styles
8

Mills, Marsha A. "Paradoxical interventions with severe conduct-disordered adolescents research of treatment effectiveness /." Morgantown, W. Va. : [West Virginia University Libraries], 2000. http://etd.wvu.edu/templates/showETD.cfm?recnum=1709.

Full text
Abstract:
Thesis (Ph. D.)--West Virginia University, 2000.
Title from document title page. Document formatted into pages; contains xii, 115 p. : ill. Includes abstract. Includes bibliographical references (p. 78-90).
APA, Harvard, Vancouver, ISO, and other styles
9

Murphy, Jennifer Mary. "The role of the amygdalar circuit in adolescent antisocial behavior /." Digital version accessible at:, 2000. http://wwwlib.umi.com/cr/utexas/main.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Farquharson, Anja B. "The effect of hopelessness on students engaged in pattern misbehavior a replication /." Online version, 2002. http://www.uwstout.edu/lib/thesis/2002/2002farquharsona.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Conduct disorders"

1

Conduct disorder. New York: Rosen Publishing, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Toth, Michele. Understanding and treating conduct disorders. Austin, Tex: Pro-Ed, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kazdin, Alan E. Conduct disorders in childhood and adolescence. 2nd ed. Thousand Oaks, Calif: Sage Publications, Inc., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Conduct disorders and severe antisocial behavior. New York: Plenum Press, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Frick, Paul J. Conduct Disorders and Severe Antisocial Behavior. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5343-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Conduct disorders in childhood and adolescence. Newbury Park, Calif: Sage Publications, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gilliam, James E. Conduct disorder scale: Examiner's manual. Austin, Tex: Pro-ed, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kernberg, Paulina F. Children with conduct disorders: A psychotherapy manual. [New York]: Basic Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gardner, Richard A. Conduct disorders of childhood: Psychodynamics and psychotherapy. Cresskill, N.J: Creative Therapeutics, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

V, Sayger Thomas, ed. Treating conduct and oppositional defiant disorders in children. New York: Pergamon Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Conduct disorders"

1

Frick, Paul J. "Conduct Disorders." In Handbook of Child Psychopathology, 213–37. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5905-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gardner, William I., and Christine L. Cole. "Conduct Disorders." In Applied Clinical Psychology, 163–94. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-0983-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Baum, Cynthia G. "Conduct Disorders." In Handbook of Child Psychopathology, 171–96. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4757-1162-2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Martin, Barclay, and Jeffrey A. Hoffman. "Conduct Disorders." In Handbook of Developmental Psychopathology, 109–18. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4615-7142-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kazdin, Alan E. "Conduct Disorders." In International Handbook of Behavior Modification and Therapy, 669–706. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0523-1_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Canal, Ricardo. "Conduct Disorder." In Encyclopedia of Autism Spectrum Disorders, 774–82. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1698-3_407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Canal-Bedia, Ricardo. "Conduct Disorder." In Encyclopedia of Autism Spectrum Disorders, 1–9. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-6435-8_407-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Canal-Bedia, Ricardo. "Conduct Disorder." In Encyclopedia of Autism Spectrum Disorders, 1169–77. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-319-91280-6_407.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Clanton, Roberta L., Rosalind H. Baker, Jack C. Rogers, and Stéphane A. De Brito. "Conduct Disorder." In Handbook of DSM-5 Disorders in Children and Adolescents, 499–527. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57196-6_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Frick, Paul J. "Classification of Conduct Disorders." In Conduct Disorders and Severe Antisocial Behavior, 21–39. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5343-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Conduct disorders"

1

Georgoulas, Nikolaos. "Behavioral disorders in children." In 6th International e-Conference on Studies in Humanities and Social Sciences. Center for Open Access in Science, Belgrade, 2020. http://dx.doi.org/10.32591/coas.e-conf.06.17201g.

Full text
Abstract:
The child and adolescent psychopathology have been categorized into two broad classes, emotional (also called internalizing) and behavioral (externalizing) problems (disorders). In this paper, we describe the behavioral disorders in children. Behavioral problems are characterized by behaviors that are harmful and disruptive to others. Disruptive behavior disorders include attention deficit hyperactivity disorder (ADHD), conduct disorder and oppositional defiant disorder. These behavioral disorders, attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder and conduct disorder in childhood and adolescence period will be discussed in more detail.
APA, Harvard, Vancouver, ISO, and other styles
2

Georgoulas, Nikolaos. "Behavioral disorders in children." In 6th International e-Conference on Studies in Humanities and Social Sciences. Center for Open Access in Science, Belgrade, 2020. http://dx.doi.org/10.32591/coas.e-conf.06.17201g.

Full text
Abstract:
The child and adolescent psychopathology have been categorized into two broad classes, emotional (also called internalizing) and behavioral (externalizing) problems (disorders). In this paper, we describe the behavioral disorders in children. Behavioral problems are characterized by behaviors that are harmful and disruptive to others. Disruptive behavior disorders include attention deficit hyperactivity disorder (ADHD), conduct disorder and oppositional defiant disorder. These behavioral disorders, attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder and conduct disorder in childhood and adolescence period will be discussed in more detail.
APA, Harvard, Vancouver, ISO, and other styles
3

Umairah, Siti, Vanessa Adela Putri, Rosyida Rosyida, and Raihanatu Binqalbi Ruzain. "Effectiveness of Holistic Self Care to Overcome Work-Related Skeletal Muscle Disorder in Palm Workers Using Harvasting Tool Dodos: A Systematic Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.02.39.

Full text
Abstract:
Background: Oil palm Dodos workers manually harvest the palm fresh fruit which can cause work related musculoskeletal disorders (WMSDS). Holistic self-care by combining stretching exercises and breathing techniques is believed to be able to overcome work related skeletal muscle disorders. The study aimed to conduct a systematic review of research articles identifying the effectiveness of holistic self-care in overcoming work-related skeletal muscle disorders in Riau palm Dodos workers, and identifying the frequency of implementing holistic self-care. Subject and Method: A systematic review was conducted through electronic database, including Google scholar, Science Open, and ScienceDirect. The keywords used were “musculoskeletal disorders” AND “stretching exercise” AND “breathing technique”. The articles were collected between 2009 to 2020. Results: The article analysis used in this study were 4 articles. The effectiveness of holistic self-care (stretching exercise and breathing technique) showed 30 minutes of exercise per day for 5 days per week for a period of 6 weeks can overcome the skeletal muscle disorders caused by work related neck, shoulder, upper, and low back pain in workers. Conclusion: Holistic self-care (stretching exercise and breathing technique) overcomes work related musculoskeletal disorders in workers. Keywords: work related musculoskeletal disorders, holistic self-care. Correspondence: Siti Umairah. Psychology Study Program, Faculty of Psychology, University of Islamic Riau, Pekanbaru, Riau, Indonesia. Email: pujaumayrah@gmail.com. Mobile: +628 2250453378. DOI: https://doi.org/10.26911/the7thicph.02.39
APA, Harvard, Vancouver, ISO, and other styles
4

Albuquerque, Pedro José Honório de, Laura Guerra Lopes, Jordy Silva de Carvalho, Luzilene Pereira de Lima, and Marina Galdino da Rocha Pitta. "Emerging therapies for amyotrophic lateral sclerosis applied to drug discovery." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.021.

Full text
Abstract:
Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive neuromuscular disease mainly caused by genetic disorders. This progressive disorder involves the degeneration of motor neurons at various levels. Drugs have been studied, and they show improvement in survival and reduced progression of the disease, they are riluzole and edaravone. Objectives: Investigate emerging therapies for the treatment of ALS. Methods: The Pubmed database was used to conduct the research, and the keywords were “Amyotrophic Lateral Sclerosis”, “Emerging”, “Therapies”,”Drugs”, all present in Mesh. Articles from 2016 to 2021 were used. And the survey was conducted on May 2, 2021. Results: Only two drugs have been approved yet by the Food and Drug Administration for the treatment of ALS, riluzole and edaravone, and each one offers modest benefits in mortality and/or function. On the other hand, 88 studies of clinical intervention trials are active using different drugs. Current therapies under development include oral tyrosine kinase inhibitors (masitinib, trametinib); the antisense oligonucleotide (tofersen); the human monoclonal antibody inhibitor (ravulizumab); and mesenchymal stem cells (MSC); among others (RT001, Enoxacin, Engensis, ANX005, Deferiprone). Conclusions: Due to gaps in the knowledge of the specific pathophysiology of ALS, the definitive treatment is still a mystery. The drugs currently in use, riluzole and edaravone, are the most promising in terms of delaying the progression of the disease.
APA, Harvard, Vancouver, ISO, and other styles
5

Mazur, Anna. "The structure of the relationship between physical activity and psychosocial functioning of women and men during the COVID-19 epidemic in Poland." In 2nd International Neuropsychological Summer School named after A. R. Luria “The World After the Pandemic: Challenges and Prospects for Neuroscience”. Ural University Press, 2020. http://dx.doi.org/10.15826/b978-5-7996-3073-7.11.

Full text
Abstract:
Since the COVID.19 pandemic is a serious crisis in many countries around the world, it is important to conduct empirical research aimed at identifying risks and factors protecting the functioning of people affected by it [1, 2]. For this reason, the goal of this research is to determine the structure of the relationship between physical activity and psychosocial functioning of 226 women and 226 men during the COVID.19 epidemic in Poland by looking at connections between physical activity, mental health disorders and cognitive processes and their significance for the quality of social relations. Methodologically, the research relies on IPAQ Questionnaire [3], GHQ-28 Questionnaires [4], TUS Test — 6/9 version [5] and the original SFS Scale. The structural model indicates that physical activity weakens the relationship between mental health disorders and cognitive processes, and gender is the moderator of these relationships. This suggests that physical activity adapted to the condition of health may be an important component of gender. individualized psycho. preventive interventions.
APA, Harvard, Vancouver, ISO, and other styles
6

Romanova, Olga Leonidovna, Dmitriy Vadimovich Sundukov, Arkadiy Mikhailovich Golubev, and Mikhail Lvovich Blagonravov. "FEATURES OF PATHOLOGICAL CHANGES IN THE LUNGS DURING POISONING WITH A COMBINATION OF BACLOFEN AND ETHANOL." In IV Международная научно-практическая конференция "Научные исследования и инновации". KDU, Moscow, 2021. http://dx.doi.org/10.31453/kdu.ru.978-5-7913-1168-9-2021-219-223.

Full text
Abstract:
To date, poisoning hold one of the leading positions in the structure of violent death. There is a large number of poisoning with the muscle relaxant baclofen. The aim of the study was to conduct a qualitative assessment of histomorphological changes in the lungs in acute combined poisoning with baclofen and ethanol 3 hours after the administration of the drug. When a combination of baclofen and ethanol is administered, a complex of general pathological processes develops in the lungs, which includes circulatory disorders (venular and capillary plethora, sludge), increased vascular permeability in conditions of developing hypoxia, and WBC infiltration of the interalveolar septi. In order to quantify the severity of the pathological process in the lungs and further study its dynamics a morphometric study is to be conducted.
APA, Harvard, Vancouver, ISO, and other styles
7

DeVries, Nicole A., Anup A. Gandhi, Douglas C. Fredericks, Joseph D. Smucker, and Nicole M. Grosland. "In Vitro Study of the C2-C7 Sheep Cervical Spine." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53167.

Full text
Abstract:
Due to the limited availability of human cadaveric specimens, animal models are often utilized for in vitro studies of various spinal disorders and surgical techniques. Sheep spines have similar geometry, disc space, and lordosis as compared to humans [1,2]. Several studies have identified the geometrical similarities between the sheep and human spine; however these studies have been limited to quantifying the anatomic dimensions as opposed to the biomechanical responses [2–3]. Although anatomical similarities are important, biomechanical correspondence is imperative to understand the effects of disorders, surgical techniques, and implant designs. Some studies [3–5] have focused on experimental biomechanics of the sheep cervical functional spinal units (FSUs). Szotek and colleagues [1] studied the biomechanics of compression and impure flexion-extension for the C2-C7 intact sheep spine. However, to date, there is no comparison of the sheep spine using pure flexion-extension, lateral bending, or axial rotation moments for multilevel specimen. Therefore, the purpose of this study was to conduct in vitro testing of the intact C2-C7 sheep cervical spine.
APA, Harvard, Vancouver, ISO, and other styles
8

Seijo, N. "No One is on My Side: The Role of Abuse in Eating Disorders." In Scientific achievements of the third millennium. SPC "LJournal", 2021. http://dx.doi.org/10.18411/scienceconf-06-2021-22.

Full text
Abstract:
Eating disorders are considered some of the most difficult to treat and have the highest mortality rate of all mental disorders (Agras, 2001). Among them, anorexia nervosa is one of the psychiatric diagnoses with the highest mortality rate (Arcelus et al., 2011). In a longitudinal study conducted by Bulkin et al. (2007) from 1980 to 2005, it was found that applying medication and working with behavior yielded inconclusive results (Openshaw, et al. 2004). If eating disorders were solely dependent on food, it would make sense that changing eating behaviors makes it easier to get out of the disorder. Unfortunately, however, this is often not the case. The clinical case presented here is a clear example of the relationship between eating disorders and trauma, particularly sexual, emotional, power, and physical abuse.
APA, Harvard, Vancouver, ISO, and other styles
9

Seijo, N. "No One is on My Side: The Role of Abuse in Eating Disorders." In General question of world science. Наука России, 2021. http://dx.doi.org/10.18411/gq-31-07-2021-20.

Full text
Abstract:
Eating disorders are considered some of the most difficult to treat and have the highest mortality rate of all mental disorders (Agras, 2001). Among them, anorexia nervosa is one of the psychiatric diagnoses with the highest mortality rate (Arcelus et al., 2011). In a longitudinal study conducted by Bulkin et al. (2007) from 1980 to 2005, it was found that – 80 – General question of world science applying medication and working with behavior yielded inconclusive results (Openshaw, et al. 2004). If eating disorders were solely dependent on food, it would make sense that changing eating behaviors makes it easier to get out of the disorder. Unfortunately, however, this is often not the case. The clinical case presented here is a clear example of the relationship between eating disorders and trauma, particularly sexual, emotional, power, and physical abuse.
APA, Harvard, Vancouver, ISO, and other styles
10

"CANNABIS USE AND ANXIETY DISORDERS DURING PREGNANCY - DUAL DISORDER TO DUAL PATIENTS." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p144s.

Full text
Abstract:
Objectives From clinical cases of patients observed in Perinatal Psychiatry - Setúbal Hospital Center (Portugal), we conducted a review of the impact of both cannabis use and anxiety disorders during pregnancy. Methods and material Case reports and literature review of PubMed for cannabis use, anxiety disorders and pregnancy. Results and conclusions In Outpatient Perinatal Psychiatry we observed women with anxiety disorders who reported using cannabis during pregnancy. Indeed, pregnancy is a highly vulnerable period to the onset or worsening of previous anxiety symptoms. Anxiety disorders may adversely impact not only the mother, but also fetal maturation and child development. In fact, preterm labor and low birth weight are consistently linked with anxiety during pregnancy. Recent studies reveal a general increase in the use of cannabis during pregnancy, representing the most commonly used illicit drug during the perinatal period. The endocannabinoid system appears to be involved in the regulation of human fertility and pregnancy. Although still conflicting, there is data demonstrating that cannabis use during pregnancy is associated with stillbirth, preterm birth, small for gestational age, low birth weight, smaller head circumferences and increased admission to neonatal intensive care units. The use of cannabis during pregnancy is frequently a way to improve symptoms of anxiety disorders. All patients should be screened to substance use comorbid to other frequent psychiatric disorders during pregnancy, such as anxiety disorders, in order to improve the health and well-being not only of the mother, but also of the developing baby, as a dual disorder has a negative effect in both individuals.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Conduct disorders"

1

Viswanathan, Meera, Jennifer Cook Middleton, Alison Stuebe, Nancy Berkman, Alison N. Goulding, Skyler McLaurin-Jiang, Andrea B. Dotson, et al. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions. Agency for Healthcare Research and Quality (AHRQ), April 2021. http://dx.doi.org/10.23970/ahrqepccer236.

Full text
Abstract:
Background. Untreated maternal mental health disorders can have devastating sequelae for the mother and child. For women who are currently or planning to become pregnant or are breastfeeding, a critical question is whether the benefits of treating psychiatric illness with pharmacologic interventions outweigh the harms for mother and child. Methods. We conducted a systematic review to assess the benefits and harms of pharmacologic interventions compared with placebo, no treatment, or other pharmacologic interventions for pregnant and postpartum women with mental health disorders. We searched four databases and other sources for evidence available from inception through June 5, 2020 and surveilled the literature through March 2, 2021; dually screened the results; and analyzed eligible studies. We included studies of pregnant, postpartum, or reproductive-age women with a new or preexisting diagnosis of a mental health disorder treated with pharmacotherapy; we excluded psychotherapy. Eligible comparators included women with the disorder but no pharmacotherapy or women who discontinued the pharmacotherapy before pregnancy. Results. A total of 164 studies (168 articles) met eligibility criteria. Brexanolone for depression onset in the third trimester or in the postpartum period probably improves depressive symptoms at 30 days (least square mean difference in the Hamilton Rating Scale for Depression, -2.6; p=0.02; N=209) when compared with placebo. Sertraline for postpartum depression may improve response (calculated relative risk [RR], 2.24; 95% confidence interval [CI], 0.95 to 5.24; N=36), remission (calculated RR, 2.51; 95% CI, 0.94 to 6.70; N=36), and depressive symptoms (p-values ranging from 0.01 to 0.05) when compared with placebo. Discontinuing use of mood stabilizers during pregnancy may increase recurrence (adjusted hazard ratio [AHR], 2.2; 95% CI, 1.2 to 4.2; N=89) and reduce time to recurrence of mood disorders (2 vs. 28 weeks, AHR, 12.1; 95% CI, 1.6 to 91; N=26) for bipolar disorder when compared with continued use. Brexanolone for depression onset in the third trimester or in the postpartum period may increase the risk of sedation or somnolence, leading to dose interruption or reduction when compared with placebo (5% vs. 0%). More than 95 percent of studies reporting on harms were observational in design and unable to fully account for confounding. These studies suggested some associations between benzodiazepine exposure before conception and ectopic pregnancy; between specific antidepressants during pregnancy and adverse maternal outcomes such as postpartum hemorrhage, preeclampsia, and spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary hypertension of the newborn, depression in children, and autism spectrum disorder; between quetiapine or olanzapine and gestational diabetes; and between benzodiazepine and neonatal intensive care admissions. Causality cannot be inferred from these studies. We found insufficient evidence on benefits and harms from comparative effectiveness studies, with one exception: one study suggested a higher risk of overall congenital anomalies (adjusted RR [ARR], 1.85; 95% CI, 1.23 to 2.78; N=2,608) and cardiac anomalies (ARR, 2.25; 95% CI, 1.17 to 4.34; N=2,608) for lithium compared with lamotrigine during first- trimester exposure. Conclusions. Few studies have been conducted in pregnant and postpartum women on the benefits of pharmacotherapy; many studies report on harms but are of low quality. The limited evidence available is consistent with some benefit, and some studies suggested increased adverse events. However, because these studies could not rule out underlying disease severity as the cause of the association, the causal link between the exposure and adverse events is unclear. Patients and clinicians need to make an informed, collaborative decision on treatment choices.
APA, Harvard, Vancouver, ISO, and other styles
2

Irwin, Courtney L., Patrícia S. Coelho, Bruno Kluwe-Schiavon, Anabela Silva-Fernandes, Óscar F. Gonçalves, Jorge Leite, and Sandra Carvalho. Treatment-related changes of molecular biomarkers in major depressive disorder: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2021. http://dx.doi.org/10.37766/inplasy2021.10.0105.

Full text
Abstract:
Review question / Objective: The aim of this review is two-fold: first, we sought to identify candidate biomarkers that could provide information on whether an individual with MDD would respond positively to common non-pharmacological treatments, and secondly, to conduct a meta-analysis to determine whether one form of common non-pharmacological treatment (namely CBT, tDCS and TMS) would produce better results over another in regards to its influence on biomarker levels. Information sources: The information sources used were: three online databases (PubMed, Scopus, and PsycINFO) to identify English-language human randomised controlled trials unrestricted by year of publication.
APA, Harvard, Vancouver, ISO, and other styles
3

Schnabel, Filipina, and Danielle Aldridge. Effectiveness of EHR-Depression Screening Among Adult Diabetics in an Urban Primary Care Clinic. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0003.

Full text
Abstract:
Background Diabetes mellitus (DM) and depression are important comorbid conditions that can lead to more serious health outcomes. The American Diabetes Association (ADA) supports routine screening for depression as part of standard diabetes management. The PHQ2 and PHQ9 questionnaires are good diagnostic screening tools used for major depressive disorders in Type 2 diabetes mellitus (DM2). This quality improvement study aims to compare the rate of depression screening, treatment, and referral to behavioral health in adult patients with DM2 pre and post-integration of depression screening tools into the electronic health record (EHR). Methods We conducted a retrospective chart review on patients aged 18 years and above with a diagnosis of DM2 and no initial diagnosis of depression or other mental illnesses. Chart reviews included those from 2018 or prior for before integration data and 2020 to present for after integration. Sixty subjects were randomly selected from a pool of 33,695 patients in the clinic with DM2 from the year 2013-2021. Thirty of the patients were prior to the integration of depression screening tools PHQ2 and PHQ9 into the EHR, while the other half were post-integration. The study population ranged from 18-83 years old. Results All subjects (100%) were screened using PHQ2 before integration and after integration. Twenty percent of patients screened had a positive PHQ2 among subjects before integration, while 10% had a positive PHQ2 after integration. Twenty percent of patients were screened with a PHQ9 pre-integration which accounted for 100% of those subjects with a positive PHQ2. However, of the 10% of patients with a positive PHQ2 post-integration, only 6.7 % of subjects were screened, which means not all patients with a positive PHQ2 were adequately screened post-integration. Interestingly, 10% of patients were treated with antidepressants before integration, while none were treated with medications in the post-integration group. There were no referrals made to the behavior team in either group. Conclusion There is no difference between the prevalence of depression screening before or after integration of depression screening tools in the EHR. The study noted that there is a decrease in the treatment using antidepressants after integration. However, other undetermined conditions could have influenced this. Furthermore, not all patients with positive PHQ2 in the after-integration group were screened with PHQ9. The authors are unsure if the integration of the depression screens influenced this change. In both groups, there is no difference between referrals to the behavior team. Implications to Nursing Practice This quality improvement study shows that providers are good at screening their DM2 patients for depression whether the screening tools were incorporated in the EHR or not. However, future studies regarding providers, support staff, and patient convenience relating to accessibility and availability of the tool should be made. Additional issues to consider are documentation reliability, hours of work to scan documents in the chart, risk of documentation getting lost, and the use of paper that requires shredding to comply with privacy.
APA, Harvard, Vancouver, ISO, and other styles
4

Mawassi, Munir, Adib Rowhani, Deborah A. Golino, Avichai Perl, and Edna Tanne. Rugose Wood Disease of Grapevine, Etiology and Virus Resistance in Transgenic Vines. United States Department of Agriculture, November 2003. http://dx.doi.org/10.32747/2003.7586477.bard.

Full text
Abstract:
Rugose wood is a complex disease of grapevines, which occurs in all growing areas. The disease is spread in the field by vector transmission (mealybugs). At least five elongated-phloem- limited viruses are implicated in the various rugose wood disorders. The most fully characterized of these are Grapevine virus A (GV A) and GVB, members of a newly established genus, the vitivirus. GVC, a putative vitivirus, is much less well characterized than GV A or GVB. The information regarding the role of GVC in the etiology and epidemiology of rugose wood is fragmentary and no sequence data for GVC are available. The proposed research is aimed to study the etiology and epidemiology of rugose wood disease, and to construct genetically engineered virus-resistant grapevines. The objectives of our proposed research were to construct transgenic plants with coat protein gene sequences designed to induce post-transcriptional gene silencing (pTGS); to study the epidemiology and etiology of rugose wood disease by cloning and sequencing of GVC; and surveying of rugose wood- associated viruses in Californian and Israeli vineyards. In an attempt to experimentally define the role of the various genes of GV A, we utilized the infectious clone, inserted mutations in every ORF, and studied the effect on viral replication, gene expression, symptoms and viral movement. We explored the production of viral RNAs in a GV A-infected Nicotiana benthamiana herbaceous host, and characterized one nested set of three 5'-terminal sgRNAs of 5.1, 5.5 and 6.0 kb, and another, of three 3'-terminal sgRNAs of 2.2, 1.8 and 1.0 kb that could serve for expression of ORFs 2-3, respectively. Several GV A constructs have been assembled into pCAMBIA 230 I, a binary vector which is used for Angrobacterium mediated transformation: GV A CP gene; two copies of the GV A CP gene arranged in the same antisense orientation; two copies of the GV A CP gene in which the downstream copy is in an antigens orientation; GV A replicase gene; GV A replicase gene plus the 3' UTR sequence; and the full genome of GV A. Experiments for transformation of N. benthamiana and grapevine cell suspension with these constructs have been initiated. Transgenic N. benthamiana plants that contained the CP gene, the replicase gene and the entire genome of GV A were obtained. For grapevine transformation, we have developed efficient protocols for transformation and successfully grapevine plantlets that contained the CP gene and the replicase genes of GV A were obtained. These plants are still under examination for expression of the trans genes. The construction of transgenic plants with GV A sequences will provide, in the long run, a means to control one of the most prevalent viruses associated with grapevines. Our many attempts to produce a cDNA library from the genome of GVC failed. For surveying of rugose wood associated viruses in California vineyards, samples were collected from different grape growing areas and tested by RT-PCR for GV A, GVB and GVD. The results indicated that some of the samples were infected with multiple viruses, but overall, we found higher incidence of GVB and GV A infection in California vineyards and new introduction varieties, respectively. In this research we also conducted studies to increase our understanding of virus - induced rootstock decline and its importance in vineyard productivity. Our results provided supporting evidence that the rootstock response to virus infection depends on the rootstock genotype and the virus type. In general, rootstocks are differ widely in virus susceptibility. Our data indicated that a virus type or its combination with other viruses was responsible in virus-induced rootstock decline. As the results showed, the growth of the rootstocks were severely affected when the combination of more than one virus was present.
APA, Harvard, Vancouver, ISO, and other styles
5

Chou, Roger, Jesse Wagner, Azrah Y. Ahmed, Ian Blazina, Erika Brodt, David I. Buckley, Tamara P. Cheney, et al. Treatments for Acute Pain: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), December 2020. http://dx.doi.org/10.23970/ahrqepccer240.

Full text
Abstract:
Objectives. To evaluate the effectiveness and comparative effectiveness of opioid, nonopioid pharmacologic, and nonpharmacologic therapy in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse events, and long-term use of opioids. Data sources. Electronic databases (Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews) to August 2020, reference lists, and a Federal Register notice. Review methods. Using predefined criteria and dual review, we selected randomized controlled trials (RCTs) of outpatient therapies for eight acute pain conditions: low back pain, neck pain, other musculoskeletal pain, neuropathic pain, postoperative pain following discharge, dental pain (surgical or nonsurgical), pain due to kidney stones, and pain due to sickle cell disease. Meta-analyses were conducted on pharmacologic therapy for dental pain and kidney stone pain, and likelihood of repeat or rescue medication use and adverse events. The magnitude of effects was classified as small, moderate, or large using previously defined criteria, and strength of evidence was assessed. Results. One hundred eighty-three RCTs on the comparative effectiveness of therapies for acute pain were included. Opioid therapy was probably less effective than nonsteroidal anti-inflammatory drugs (NSAIDs) for surgical dental pain and kidney stones, and might be similarly effective as NSAIDs for low back pain. Opioids and NSAIDs were more effective than acetaminophen for surgical dental pain, but opioids were less effective than acetaminophen for kidney stone pain. For postoperative pain, opioids were associated with increased likelihood of repeat or rescue analgesic use, but effects on pain intensity were inconsistent. Being prescribed an opioid for acute low back pain or postoperative pain was associated with increased likelihood of use of opioids at long-term followup versus not being prescribed, based on observational studies. Heat therapy was probably effective for acute low back pain, spinal manipulation might be effective for acute back pain with radiculopathy, acupressure might be effective for acute musculoskeletal pain, an opioid might be effective for acute neuropathic pain, massage might be effective for some types of postoperative pain, and a cervical collar or exercise might be effective for acute neck pain with radiculopathy. Most studies had methodological limitations. Effect sizes were primarily small to moderate for pain, the most commonly evaluated outcome. Opioids were associated with increased risk of short-term adverse events versus NSAIDs or acetaminophen, including any adverse event, nausea, dizziness, and somnolence. Serious adverse events were uncommon for all interventions, but studies were not designed to assess risk of overdose, opioid use disorder, or long-term harms. Evidence on how benefits or harms varied in subgroups was lacking. Conclusions. Opioid therapy was associated with decreased or similar effectiveness as an NSAID for some acute pain conditions, but with increased risk of short-term adverse events. Evidence on nonpharmacological therapies was limited, but heat therapy, spinal manipulation, massage, acupuncture, acupressure, a cervical collar, and exercise were effective for specific acute pain conditions. Research is needed to determine the comparative effectiveness of therapies for sickle cell pain, acute neuropathic pain, neck pain, and management of postoperative pain following discharge; effects of therapies for acute pain on non-pain outcomes; effects of therapies on long-term outcomes, including long-term opioid use; and how benefits and harms of therapies vary in subgroups.
APA, Harvard, Vancouver, ISO, and other styles
6

McDonagh, Marian S., Jesse Wagner, Azrah Y. Ahmed, Rongwei Fu, Benjamin Morasco, Devan Kansagara, and Roger Chou. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain. Agency for Healthcare Research and Quality (AHRQ), October 2021. http://dx.doi.org/10.23970/ahrqepccer250.

Full text
Abstract:
Objectives. To evaluate the evidence on benefits and harms of cannabinoids and similar plant-based compounds to treat chronic pain. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases, reference lists of included studies, submissions received after Federal Register request were searched to July 2021. Review methods. Using dual review, we screened search results for randomized controlled trials (RCTs) and observational studies of patients with chronic pain evaluating cannabis, kratom, and similar compounds with any comparison group and at least 1 month of treatment or followup. Dual review was used to abstract study data, assess study-level risk of bias, and rate the strength of evidence. Prioritized outcomes included pain, overall function, and adverse events. We grouped studies that assessed tetrahydrocannabinol (THC) and/or cannabidiol (CBD) based on their THC to CBD ratio and categorized them as high-THC to CBD ratio, comparable THC to CBD ratio, and low-THC to CBD ratio. We also grouped studies by whether the product was a whole-plant product (cannabis), cannabinoids extracted or purified from a whole plant, or synthetic. We conducted meta-analyses using the profile likelihood random effects model and assessed between-study heterogeneity using Cochran’s Q statistic chi square and the I2 test for inconsistency. Magnitude of benefit was categorized into no effect or small, moderate, and large effects. Results. From 2,850 abstracts, 20 RCTs (N=1,776) and 7 observational studies (N=13,095) assessing different cannabinoids were included; none of kratom. Studies were primarily short term, and 75 percent enrolled patients with a variety of neuropathic pain. Comparators were primarily placebo or usual care. The strength of evidence (SOE) was low, unless otherwise noted. Compared with placebo, comparable THC to CBD ratio oral spray was associated with a small benefit in change in pain severity (7 RCTs, N=632, 0 to10 scale, mean difference [MD] −0.54, 95% confidence interval [CI] −0.95 to −0.19, I2=28%; SOE: moderate) and overall function (6 RCTs, N=616, 0 to 10 scale, MD −0.42, 95% CI −0.73 to −0.16, I2=24%). There was no effect on study withdrawals due to adverse events. There was a large increased risk of dizziness and sedation and a moderate increased risk of nausea (dizziness: 6 RCTs, N=866, 30% vs. 8%, relative risk [RR] 3.57, 95% CI 2.42 to 5.60, I2=0%; sedation: 6 RCTs, N=866, 22% vs. 16%, RR 5.04, 95% CI 2.10 to 11.89, I2=0%; and nausea: 6 RCTs, N=866, 13% vs. 7.5%, RR 1.79, 95% CI 1.20 to 2.78, I2=0%). Synthetic products with high-THC to CBD ratios were associated with a moderate improvement in pain severity, a moderate increase in sedation, and a large increase in nausea (pain: 6 RCTs, N=390 to 10 scale, MD −1.15, 95% CI −1.99 to −0.54, I2=39%; sedation: 3 RCTs, N=335, 19% vs. 10%, RR 1.73, 95% CI 1.03 to 4.63, I2=0%; nausea: 2 RCTs, N=302, 12% vs. 6%, RR 2.19, 95% CI 0.77 to 5.39; I²=0%). We found moderate SOE for a large increased risk of dizziness (2 RCTs, 32% vs. 11%, RR 2.74, 95% CI 1.47 to 6.86, I2=0%). Extracted whole-plant products with high-THC to CBD ratios (oral) were associated with a large increased risk of study withdrawal due to adverse events (1 RCT, 13.9% vs. 5.7%, RR 3.12, 95% CI 1.54 to 6.33) and dizziness (1 RCT, 62.2% vs. 7.5%, RR 8.34, 95% CI 4.53 to 15.34). We observed a moderate improvement in pain severity when combining all studies of high-THC to CBD ratio (8 RCTs, N=684, MD −1.25, 95% CI −2.09 to −0.71, I2=50%; SOE: moderate). Evidence on whole-plant cannabis, topical CBD, low-THC to CBD, other cannabinoids, comparisons with active products, and impact on use of opioids was insufficient to draw conclusions. Other important harms (psychosis, cannabis use disorder, and cognitive effects) were not reported. Conclusions. Low to moderate strength evidence suggests small to moderate improvements in pain (mostly neuropathic), and moderate to large increases in common adverse events (dizziness, sedation, nausea) and study withdrawal due to adverse events with high- and comparable THC to CBD ratio extracted cannabinoids and synthetic products in short-term treatment (1 to 6 months). Evidence for whole-plant cannabis, and other comparisons, outcomes, and PBCs were unavailable or insufficient to draw conclusions. Small sample sizes, lack of evidence for moderate and long-term use and other key outcomes, such as other adverse events and impact on use of opioids during treatment, indicate that more research is needed.
APA, Harvard, Vancouver, ISO, and other styles
7

Conduct Disorders and Aggression. ACAMH, September 2021. http://dx.doi.org/10.13056/acamh.17110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Comorbid anxiety disorder has a protective effect in conduct disorder. ACAMH, March 2019. http://dx.doi.org/10.13056/acamh.10622.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Childhood behaviour patterns linked with romantic partnering in adulthood. ACAMH, March 2021. http://dx.doi.org/10.13056/acamh.15027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cortical thickness can differentiate conduct disorder subtypes. ACAMH, March 2019. http://dx.doi.org/10.13056/acamh.10621.

Full text
Abstract:
A study by Graeme Fairchild and colleagues has used a neuroimaging approach to compare the structural organization (or “covariance”) of brain regions between youths with different subtypes of conduct disorder (CD) and healthy controls (HC).
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Conduct disorders' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography